Suchergebnisse - "Liao, Ran"

PubPharm (5)

1

Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity : The SURMOUNT-4 Randomized Clinical Trial

enthalten in: JAMA | 2024

von Aronne, L. | Sattar, N. | Horn, D. | +85

2

Baricitinib in juvenile idiopathic arthritis : an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial

enthalten in: Lancet (London, England) | 2023

von Ramanan, A. | Quartier, P. | Okamoto, N. | +105

CommentIn: Lancet. 2023 Aug 12;402(10401):508-509. - PMID 37423229

3

Efficacy and safety of baricitinib in combination with topical corticosteroids in patients with moderate-to-severe atopic dermatitis with inadequate response, intolerance or contraindication to ciclosporin : results from a randomized, placebo-controlled, phase III clinical trial (BREEZE-AD4)

enthalten in: The British journal of dermatology | 2022

von Bieber, T. | Reich, K. | Paul, C. | +13

4

Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation : an exploratory, randomised, placebo-controlled trial

enthalten in: The Lancet. Respiratory medicine | 2022

von Ely, E. | Ramanan, A. | Kartman, C. | +25

CommentIn: Lancet Respir Med. 2022 Apr;10(4):314-315. - PMID 35123659

5

Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER) : a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial

enthalten in: The Lancet. Respiratory medicine | 2021

von Marconi, V. | Ramanan, A. | de Bono, S. | +105

CommentIn: Lancet Respir Med. 2021 Dec;9(12):1349-1351. - PMID 34480862

1
[1]